Arrhythmia pharmacogenomics: Methodological considerations

Current Pharmaceutical Design

Volumn 15, Issue 32, 2009, Pages 3734-3741

  Roden, Dan M ^a   Kannankeril, Prince J ^a   Darbar, Dawood ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL; NEURONAL NITRIC OXIDE SYNTHASE; NUCLEOPORIN; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KV1.5; PROTEIN NOS1AP; PROTEIN NUP155; SODIUM CHANNEL; SODIUM CHANNEL SCN1B; SODIUM CHANNEL SCN2B; TRANSCRIPTION FACTOR PITX2; UNCLASSIFIED DRUG;

DEFIBRILLATOR; DRUG INDUCED DISEASE; DRUG RESPONSE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE FIBRILLATION; HUMAN; LONG QT SYNDROME; NONHUMAN; PHARMACOGENOMICS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; SUDDEN DEATH; TORSADE DES POINTES;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; HUMANS; PHARMACOGENETICS; PHENOTYPE;

EID: 70449717514     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209789649529     Document Type: Review

References (89)

1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-952 (Pubitemid 28446646)
2. Spooner PM, Albert C, Benjamin EJ, Boineau R, Elston RC, George AL, Jr. et al. Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation 2001; 103: 2361-2364 (Pubitemid 32448800)
3. Fox CS, Parise H, D'Agostino RB, Sr, Lloyd-Jones DM, Vasan RS, Wang TJ, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA: J Am Med Assoc 2004; 291: 2851-2855 (Pubitemid 38747806)
4. Darbar D, Herron KJ, Ballew JD, Jahangir A, Gersh BJ, Shen WK et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 2003; 41: 2185-2192 (Pubitemid 36724265)
5. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-2891 (Pubitemid 33139098)
6. Murray KT, Rottman JN, Arbogast PG, Shemanski L, Primm RK, Campbell WB et al. Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm 2004; 1: 669-675 (Pubitemid 40028772)
7. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999; 100: 376-380 (Pubitemid 29362407)
8. Madrid AH, Bueno MG, Rebollo JM, Marin I, Pena G, Bernal E, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002; 106: 331-336 (Pubitemid 34778957)
9. Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001; 89: E32-8.
10. Steinberg JS. Postoperative atrial fibrillation: a billion-dollar problem. J Am Coll Cardiol 2004; 43: 1001-1003 (Pubitemid 38352979)
11. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833 (Pubitemid 35417773)
12. Oral H, Chugh A, Good E, Sankaran S, Reich SS, Igic P, et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation 2006; 113: 1824-1831 (Pubitemid 43739393)
13. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351: 2373-2383 (Pubitemid 40500183)
14. Singer DE. Overview of the randomized trials to prevent stroke in atrial fibrillation. Ann Epidemiol 1993; 3: 563-567
15. Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, McLeod HL, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 2005; 352: 2285-2293
16. Schwarz UI, Ritchie MD, Bradford Y, Li C, Dudek SM, Frye-Anderson A, et al. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med 2008; 358: 999-1008. (Pubitemid 351347099)
17. Shurin SB, Nabel EG. Pharmacogenomics - ready for prime time? N Engl J Med 2008; 358: 1061-1063
18. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137-1140 (Pubitemid 14135387)
19. Vreede-Swagemakers JJM, Gorgels AP, Duboisarbouw WI, Vanree JW, Daemen MJAP, Houben LGE, et al. Out-of-hospital cardiac arrest in the 1990s - a population-based study in the maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997; 30: 1500-1505
20. The CAST Investigators. Preliminary Report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-412
21. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e385-484.
22. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999; 99: 529-533 (Pubitemid 29061868)
23. Roden DM. Clinical practice. Long-QT syndrome. N Engl J Med 2008; 358: 169-176
24. DaTorre SD, Creer MH, Pogwizd SM, Corr PB. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol 1991; 23 (Suppl 1): 11-22.
25. Roden DM, Viswanathan PC. Genetics of acquired long QT syndrome. J Clin Invest 2005; 115: 2025-2032
26. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993; 270: 2590-2597
27. Husser D, Stridh M, Sornmo L, Roden DM, Darbar D, Bollmann A. A genotype dependent intermediate ECG phenotype in patients with persistent lone atrial fibrillation. Circ Arrhythmia Electrophysiol 2009; 2(1): 24-28
28. Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, Ikeda M, et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 2006; 38: 644-651 (Pubitemid 43927305)
29. Chang KC, Barth AS, Sasano T, Kizana E, Kashiwakura Y, Zhang Y, et al. CAPON modulates cardiac repolarization neuronal nitric oxide synthase signaling in the heart. Proc Natl Acad Sci USA 2008; 105: 4477-4482 (Pubitemid 351754405)
30. Milan DJ, Peterson TA, Ruskin JN, Peterson RT, Macrae CA. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 2003; 107: 1355-1358
31. Milan DJ, Jones IL, Amsterdam AH, Rosenbaum DS, Roden D, MacRae CA. Abstract 637: A pharmacogenetic screen for modifiers of drug induced QT prolongation reveals 15 novel genes. Circulation 2007; 116: II.
32. Kaab S, Darbar D, van NC, Dupuis J, Pfeufer A, Newton-Cheh C, et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J 2009.
33. Aarnoudse AJ, Newton-Cheh C, de Bakker PIW, Straus SMJM, Kors JA, Hofman A, et al. Common NOS1AP Variants Are Associated With a Prolonged QTc Interval in the Rotterdam Study. Circulation 2007; 116: 10-16 (Pubitemid 47016241)
34. Kao WH, Arking DE, Post W, Rea TD, Sotoodehnia N, Prineas RJ, et al. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation 2009; 119(7): 940-951
35. Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation 1999; 99: 1978-1983 (Pubitemid 29183894)
36. Friedlander Y, Siscovick DS, Weinmann S, Austin MA, Psaty BM, Lemaitre RN, et al. Family history as a risk factor for primary cardiac arrest. Circulation 1998; 97: 155-160 (Pubitemid 28124672)
37. Dekker LRC, Bezzina CR, Henriques JPS, Tanck MW, Koch KT, Alings MW, et al. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation 2006; 114: 1140-1145
38. Kaab S, Pfeufer A, Hinterseer M, Nabauer M, Yalilzadeh S, George AL, et al. Common gene variants associated with drug induced long-QT syndrome. Circulation 2005; (Abstr.)
39. Roden DM, Pulley JM, Basford MA, Bernard GR, Clayton EW, Balser JR, et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther 2008; 84: 362-369
40. Crawford DC, Ritchie MD, Denny JC, Havens A, Weiner J, Pulley J, et al. Electronic Medical Records Linked to DNA: A Valuable Resource for Large-Scale Genetic Association Studies. Am Soc Hum Genet 2008; accepted for presentation (Abstr.)
41. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997; 336: 905-911 (Pubitemid 27137190)
42. Ellinor PT, Shin JT, Moore RK, Yoerger DM, Macrae CA. Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation 2003; 107: 2880-2883 (Pubitemid 36736626)
43. Darbar D, Hardy A, Haines JL, Roden DM. Prolonged signal-averaged P-wave duration as an intermediate phenotype for familial atrial fibrillation. J Am Coll Cardiol 2008; 51: 1083-1089
44. Oberti C, Wang L, Li L, Dong J, Rao S, Du W, et al. Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy. Circulation 2004; 110: 3753-3759 (Pubitemid 40023972)
45. Zhang X, Chen S, Yoo S, Chakrabarti S, Zhang T, Ke T, et al. Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell 2008; 135: 1017-1027
46. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003; 299: 251-254 (Pubitemid 36125211)
47. Rhodes TE, Manderfield LJ, Lundquist AL, George AL, Donahue BS, Roden DM, Darbar D. Gain-of-function KCNQ1 and KCNE3 Mutations Associated with Atrial Fibrillation. Circulation Accepted for presentation, AHA 2006; Scientific sessions: (Abstr.)
48. Otway R, Vandenberg JI, Guo G, Varghese A, Castro ML, Liu J, et al. Stretch-sensitive KCNQ1 mutation: a link between genetic and environmental factors in the pathogenesis of atrial fibrillation? J Am Coll Cardiol 2007; 49: 578-586
49. Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A, et al. A novel Form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 2005; 96(7): 800-807 (Pubitemid 40559520)
50. Yang Y, Xia M, Jin Q, Bendahhou S, Shi J, Chen Y, et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004; 75: 899-905. (Pubitemid 39390498)
51. Olson TM, Alekseev AE, Moreau C, Liu XK, Zingman LV, Miki T, et al. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin Pract Cardiovasc Med 2007; 4: 110-116 (Pubitemid 46165273)
52. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007; 115: 442-449 (Pubitemid 46184195)
53. Hodgson-Zingman DM, Karst ML, Zingman LV, Heublein DM, Darbar D, Herron KJ, et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med 2008; 359: 158-165 (Pubitemid 351962039)
54. Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M, et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet 2006; 15: 2185-2191 (Pubitemid 43985509)
55. Kusano KF, Taniyama M, Nakamura K, Miura D, Banba K, Nagase S, et al. Atrial fibrillation in patients with brugada syndrome: relationships of gene mutation, electrophysiology, and clinical backgrounds. J Am Coll Cardiol 2008; 51: 1169-1175
56. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome. report of the second consensus conference. endorsed by the heart rhythm society and the european heart rhythm association. Circulation 2005; 111: 429-440
57. Chen PS, Priori SG. The Brugada Syndrome. J Am Coll Cardiol 2008; 51: 1176-1180
58. Watanabe H, Koopmann TT, Le SS, Yang T, Ingram CR, Schott JJ, et al. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest 2008; 118: 2260-2268 (Pubitemid 351872343)
59. London B, Michalec M, Mehdi H, Zhu X, Kerchner L, Sanyal S, et al. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation 2007; 116: 2260-2268 (Pubitemid 350100331)
60. Watanabe H, Darbar D, Ingram CR, Jiramongkolchai K, Chopra SS, Kucera G, et al. 2007. Loss of Function Mutations in Sodium Channel Beta Subunits Associated with Atrial Fibrillation and ST-segment elevation. Accepted for presentation, American Heart Association annual scientific sessions. Circulation 2007; 116: (Abstr.)
61. Junttila MJ, Raatikainen MJ, Perkiomaki JS, Hong K, Brugada R, Huikuri HV. Familial clustering of lone atrial fibrillation in patients with saddleback-type ST-segment elevation in right precordial leads. Eur Heart J 2007; 28: 463-468 (Pubitemid 47343561)
62. Darbar D, Kannankeril PJ, Donahue BS, Kucera G, Stubblefield T, Haines JL, et al. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 2008; 117: 1927-1935.
63. Priori SG, Napolitano C, Schwartz PJ, Bloise R, Crotti L, Ronchetti E. The elusive link between LQT3 and brugada syndrome: the role of flecainide challenge. Circulation 2000; 102: 945-947 (Pubitemid 30656000)
64. Lai LP, Su MJ, Yeh HM, Lin JL, Chiang FT, Hwang JJ, et al. Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J 2002; 144: 485-490
65. Chen LY, Ballew JD, Herron KJ, Rodeheffer RJ, Olson TM. A common polymorphism in SCN5A is associated with lone atrial fibrillation. Clin Pharmacol Ther 2007; 81: 35-41.
66. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007; 448: 353-357 (Pubitemid 47080348)
67. Mommersteeg MTM, Brown NA, Prall OWJ, de Gier-de Vries C, Harvey RP, Moorman AFM, et al. Pitx2c and Nkx2-5 Are required for the formation and identity of the pulmonary myocardium. Circ Res 2007; 101: 902-909
68. Body, S.C, Collard, C.D, Sherman, S.K, Fox, A.A, Liu, K.Y, Ritchie, M.D, Perry, T.E, Muehlschlegel, J.D, Arnaki, S, Seidman, C.E, et al. 2009. Variation in the 4q25 chromosomal locus predicts new-onset atrial fibrillation after cardiac surgery. american heart association 2008 scientific sessions. Circulation 2008; 118: S-882 (Abstr.)
69. Gretarsdottir S, Thorleifsson G, Manolescu A, Styrkarsdottir U, Helgadottir A, Gschwendtner A, et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol 2008; 64: 402-409
70. Gaudino M, Andreotti F, Zamparelli R, Di Castelnuovo A, Nasso G, Burzotta F, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. is atrial fibrillation an inflammatory complication? Circulation 2003; 108: 195II-9.
71. Motsinger AA, Donahue BS, Brown NJ, Roden DM, Ritchie MD. Risk factor interactions and genetic effects associated with post-operative atrial fibrillation. Pac Symp Biocomput 2006; 584-95: 584-595
72. Prutkin JM, Sotoodehnia N. Genetics of sudden cardiac arrest. Prog Cardiovasc Dis 2008; 50: 390-403.
73. Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, et al. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation 2007; 115: 361-367 (Pubitemid 46148510)
74. Priori SG, Napolitano C, Giordano U, Collisani G, Memmi M. Brugada syndrome and sudden cardiac death in children. Lancet 2000; 355: 808-809 (Pubitemid 30128825)
75. Donofrio MT, Gullquist SD, O'Connell NG, Redwine FO. Fetal presentation of congenital long QT syndrome. Pediatr Cardiol 1999; 20: 441-444
76. Splawski I, Timothy KW, Tateyama M, Clancy CE, Malhotra A, Beggs AH, et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 2002; 297: 1333-1336 (Pubitemid 34913168)
77. Van Norstrand DW, Tester DJ, Ackerman MJ. Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome. Heart Rhythm 2008; 5: 712-715
78. Plant LD, Bowers PN, Liu Q, Morgan T, Zhang T, State MW, et al. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest 2006; 116: 430-435 (Pubitemid 43228360)
79. Chen S, Chung MK, Martin D, Rozich R, Tchou PJ, Wang Q. SNP S1103Y in the cardiac sodium channel gene SCN5A is associated with cardiac arrhythmias and sudden death in a white family. J Med Genet 2002; 39: 913-915 (Pubitemid 36009153)
80. Chen J, Xie X, Zhu J, Tao Q, Wang X. Single-nucleotide polymorphisms in SCN5A gene in Chinese Han population and their correlation with cardiac arrhythmias. Genet Med 2004; 6: 159. (Pubitemid 38715509)
81. Stecker EC, Sono M, Wallace E, Gunson K, Jui J, Chugh SS. Allelic variants of SCN5A and risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm 2006; 3: 697-700. (Pubitemid 43758258)
82. Sotoodehnia N, Siscovick DS, Vatta M, Psaty BM, Tracy RP, Towbin JA, et al. {beta}2-Adrenergic Receptor Genetic Variants and Risk of Sudden Cardiac Death. Circulation 2006; 113: 1842-1848.
83. Snapir A, Mikkelsson J, Perola M, Penttila A, Scheinin M, Karhunen PJ. Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death. J Am Coll Cardiol 2003; 41: 190-194 (Pubitemid 36092182)
84. Fan YM, Lehtimaki T, Rontu R, Ilveskoski E, Goebeler S, Kajander O, et al. Age-dependent association between hepatic lipase gene C-480T polymorphism and the risk of pre-hospital sudden cardiac death: the Helsinki Sudden Death Study. Atherosclerosis 2007; 192: 421-427 (Pubitemid 46735938)
85. Schwartz PJ, Wolf S. QT interval prolongation as a predictor of sudden death in patients with myocardial infarction. Circulation 1978; 56: 1074-1077 (Pubitemid 8343621)
86. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006; 47: 362-367 (Pubitemid 43063255)
87. Ali KM. Collateral effects of antiarrhythmics in pediatric age. Curr Pharm Des 2008; 14(8): 782-787
88. Karpawich PP, Pettersen MD, Gupta P, Shah N. Infants and children with tachycardia: natural history and drug administration. Curr Pharm Des 2008; 14(8): 743-752 (Pubitemid 351736429)
89. Maid G, Guerchicoff M, Falconi M, de Arenaza DP. Written consent to use the drug in children: the problem of off-label drugs. Curr Pharm Des 2008; 14(8): 776-781 (Pubitemid 351736434)